Overview

Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)

Status:
Completed

Trial end date:
2018-11-05

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and efficacy of an investigational treatment (teduglutide) in Japanese patients with PN-dependent SBS. This study will also look at how teduglutide moves through the body (pharmacokinetics).

Phase:

Phase 3

Details

Lead Sponsor:

Shire

Treatments:

Teduglutide